Clinical Technology

Adult Immunization

MASLD/MASH

Hepatitis

Hepatology

Pediatric Immunization

Colorectal Cancer

Renal Cancer

Lung Cancer

Melanoma

Skin cancer

Prostate Cancer

Breast Cancer

Cervical Cancer

Screening

PTSD

Psychosis

Panic Disorder  

Anxiety

Eating Disorders

Depression

Substance-related Disorders

ADHD

Psychiatry 

Food Allergies

Anaphylaxis

Seasonal Allergies

Allergy

Osteoporosis

Menopause

Pregnancy and Birth

Women's Health

Heart Failure

Atrial Fibrillation

Lipid disorders

Hypertension

Cardiology

Pediatrics

Psoriasis

Rosacea

Atopic Dermatitis

Dermatology

Adrenal Disorders

Thyroid Disorders 

Diabetes

Endocrinology 

Fibromyalgia

Pain Management

GERD

C Difficile Infection

Celiac disease

Irritable Bowel Syndrome 

Inflammatory Bowel Disease

Gastroenterology

Coronavirus

Hepatitis C

Influenza

HIV AIDS

Pneumonia

Sexually transmitted infections

Infectious Disease

Obesity Medicine

Psoriatic arthritis

Lupus

Rheumatoid Arthritis

Osteoarthritis

Gout

Rheumatology

Chronic Kidney Disease

Nephrology

Epilepsy

Cerebrovascular Diseases

Parkinson Disease

Alzheimer Disease/Dementia

Mental Health

Headache

Migraine

Sleep Disorders

Neurology

Pulmonary hypertension

Interstitial lung disease

Asthma

Cystic Fibrosis

COPD

Pulmonology

News

All News

Editorial Podcasts

Practice Management

Video Interviews

Media

Around the Practice

Between the Lines

ConsultantLive

Frontline Insights

Institutional Insights

Primary View

Provider Toolkits

Screening Series

Conferences

Conference Coverage

Conference Listing

Product Theater Recaps

Resources

Interactive Posters

Product Profile

Publications

Subscribe

CE/CME

Patient Care Online offers clinical news and resources for primary care clinicians, focusing on disease states, guidelines, and trends to improve care.

About Us

Advertise

Contact Us

Editorial Board

Terms and Conditions

Privacy

Do Not Sell My Information

Patient Care Online – Primary Care News and Clinical Resources

Facebook

LinkedIn

Clinical Focus

Allergy & Immunology

Endocrinology

Men’s Health

Psychiatry

Women’s Health

Business Focus

Billing and Collections

Career Planning

Coding and Documentation

Concierge Medicine

Cybersecurity

EHRs

Investing

Patient Relations

Personal Finance

Remote Patient Monitoring

Staffing

Technology

Telehealth

Value-based Care

Spotlight

VMS and Menopause

Atopic Dermatitis Provider Toolkit

Adult Immunization Provider Toolkit

Dermatology Hot Topics

1rem

Clinical Topics

Topics

 is live, offering a concise roundup of 5 leading clinical updates for primary care physicians. Below, the episode begins with a nationwide analysis showing that individuals newly diagnosed with a chronic medical condition face more than twice the risk of developing major depressive disorder compared with those without such conditions, with the highest risk occurring in the first month following diagnosis.

The discussion then turns to data from a large case-control study finding that vaginal estradiol use was not associated with an increased risk of recurrent ischemic stroke in women with a history of stroke, providing reassurance for symptom management in this population.

Also included is the US approval and launch of the first generic version of liraglutide injection for weight loss, expanding access to GLP-1 therapy for adults and adolescents with obesity. Additional evidence links GLP-1 receptor agonist use to a lower overall incidence of cancer, particularly endometrial, ovarian, and meningioma cancers.

The episode concludes with results from the STEER real-world study, which found that semaglutide was associated with lower rates of major adverse cardiovascular events compared with tirzepatide among adults with obesity and established cardiovascular disease.

The stories featured in this week's Weekly Dose podcast are further detailed here:

New Data Shows Risk of Major Depressive Disorder Spikes After a Medical Diagnosis

Vaginal Estradiol Shows No Added Risk of Repeat Stroke in Women

First Generic GLP-1 RA Approved for Weight Management in the US

GLP-1 RAs May Reduce Risk for Cancer in Adults with Obesity

Semaglutide Shows Greater CVD Risk Reduction Than Tirzepatide in Adults With Obesity

 to subscribe to the Weekly Dose podcast for more updates and news. Be sure to leave a rating and review for the show. Thanks for listening! 

Hoping to listen on your favorite podcast app? See below:

Podcasts

Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

, we cover a range of studies impacting clinical practice. We discuss patient preferences for atopic dermatitis treatment, how active transportation like cycling reduces the risk of dementia, and new findings on the safety of childhood vaccines and aluminum exposure. We also explore the link between maternal depression and parenting practices, highlighting the importance of mental health support for mothers. Tune in for these important insights shaping patient care across multiple specialties.

Editor's note: Episode timestamps produced using AI tools.

Healthcare Professionals’ Views on Nutrition and Supplements (00:00:11):


Survey results on supplements, diets, food safety, nutritional training, and challenges in nutrition counseling among healthcare professionals.

Transportation Choices and Dementia Risk (00:01:33):


Study on how cycling and mixed walking reduce dementia risk, while walking alone may increase Alzheimer’s risk.

Alzheimer Disease, Tau Pathologies, and Late-Life Mood Disorders (00:01:33):


Research linking tau accumulation and amyloid deposits to late-life depression and mood disorders in older adults.

Aluminum Exposure from Childhood Vaccines and Health Risks (00:02:59):


Large-scale study finds no link between aluminum in vaccines and autoimmune, allergic, or neurodevelopmental disorders.

Impact of Maternal Depression on Parenting and Child Development (00:04:16):


Systematic review shows maternal depression negatively affects parenting and child development, especially in early years.

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

What is the relationship between common illnesses and depression? And why is the relationship so strong? What can clinicians do now to manage both the medical illness and the depression?

Here to shed light on the bidirectional relationship between the brain and other organs and the common biologic processes that affect all organs is Andrew J. Cutler, MD, who is board-certified in internal medicine and psychiatry. Dr Cutler is on the clinical faculty in the 

Department of Psychiatry at the University of Florida

. He is also CEO and Chief Medical Officer of the 

Some key points addressed in this podcast:
• People who have chronic conditions, such as heart disease or diabetes or RA, are at risk for depression. What’s underappreciated is that this is not a reactive depression: the same biologic conditions that cause the primary medical condition can also cause changes in the brain that can trigger the depression. Thus, there is a need to screen for depression in patients with chronic illness. Aggressive management of the underlying medical illness can help prevent or diminish depression.
• Conversely, aggressive management of depression can decrease the risk of a variety of medical illnesses.
• In the context of a 10-minute office visit in a patient with a chronic illness, screening tools to identify the likelihood of depression can be administered in the waiting room.
• Commonly available tools to monitor for depression include measurement CRP: if the CRP level is elevated, it signals that the patient is overproducing cytokines-a marker of inflammation and a risk factor for depression.
• Effective antidepressant therapy can sometimes reduce CRP levels.
• There is a strong association between inflammation and various medical conditions. For example, people who are overweight or obese have elevated markers of inflammation. Abdominal fat causes inflammation, which may explain the relationship between obesity and depression.
• Inflammation can prevent neurogenesis and can be toxic to nerve cells. Thus, unmanaged inflammation can “stun” the brain.
• Readers are referred to a study by 

, which showed that the TNF antagonist infliximab may improve depressive symptoms in patients with high baseline inflammatory biomarkers.

What is the relationship between common illnesses and depression? And why is the relationship so strong? What can clinicians do now to manage both the medical illness and the depression?

Managing Physical Illness and Depression

Many people with arthritis also have depression; this has been known for many years. Now it has been established that anxiety is even more common than depression among arthritis patients, in a study published in 

by authors from the Centers for Disease Control and Prevention. In this podcast, Dr. Elizabeth Lin (who was not involved with the CDC study, but has focused on comorbid depression and pain for many years) discusses  why and how the mental health problem  as well as the physical symptoms need to be addressed and resolved. 

Dr. Lin is a family medicine physician at Group Health Institute and clinical professor of psychiatry at University of Washington Medical School in Seattle.



 1. What's new about this study?
 2. Could you tell us a little bit about how the study was done and what you think of the results?
 3. What do you think doctors should do to assess their patients who have arthritis or anxiety or depression or both?
 4. What about the risk of interactions between the two drugs? Isn't it difficult to treat patients with drugs that affect their mood as well as drugs that affect their pain?
 5. Do you think that when it comes to treating these mood disorders it would be wise to refer to a mental health professional?
 6. What about followup? How frequently should a patient who has this comordibity be seen in the office?  

Arthritis, Anxiety, and Depression: Managing a Common Comorbidity

Anxiety is more common than depression among US adults with arthritis 

Generalized Anxiety Disorder 7-item scale (GAD-7)  

Effect of improving depression care on pain and function among older adults with arthritis: A randomized controlled study. 

Pharmacotherapy of pain in depressed older adults. 

Arthritis pain and disability:  Response to collaborative depressive care. 

Anxiety is even more common than depression among people who have arthritis, a new study has shown. Here to discuss the implications for diagnosis and treatment is  Eilzabeth Lin MD, a family medicine physician who is a longstanding researcher in the field of depression and pain.

Podcast:  Arthritis, Anxiety, and Depression: Managing a Common Comorbidity

Dark chocolate just got another green light. Building on research that has linked chocolate consumption to improved blood pressure, insulin sensitivity, and cholesterol levels, a new study finds that more frequent consumption of the flavinoid-rich sweet is also associated with lower body mass index (BMI). As reported in a March issue of the 

, the positive association remained after adjustment for age and sex, intake of calories and saturated fat, mood, and activity level.

Among more than 1000 men and women aged 20 to 85 years who had no known cardiovascular disease or diabetes, frequency of chocolate consumption was associated with greater intake of calories and saturated fats and higher depression scores (CES-D); (

Are these findings another green light for dark chocolate? Some experts say “yes” as they also point to a recommended upper daily “dose.” What does this new research add to the current data on the health benefits of the flavinoid-rich sweet? Drs Payal Kohli and Christopher Cannon discuss study results and what you should tell your patients.

Depression

Latest News